Nitroprusside in decompensated heart failure: What should a clinician really know?

Cristina Opasich, Giovanni Cioffi, Alessandra Gualco

Research output: Contribution to journalArticlepeer-review


Sodium nitroprusside is an older intravenous vasodilator appropriate for acute hospital treatment of patients with congestive heart failure. It is a balanced arterial and venous vasodilator with a very short half-life, facilitating rapid titration. In general, it improves hemodynamic and clinical status by reducing systemic vascular resistance, left ventricular filling pressure, and increasing cardiac output. This review summarizes recently published literature and recent data regarding the use of this intravenous vasodilator in decompensated heart failure patients.

Original languageEnglish
Pages (from-to)182-190
Number of pages9
JournalCurrent Heart Failure Reports
Issue number3
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Emergency Medicine


Dive into the research topics of 'Nitroprusside in decompensated heart failure: What should a clinician really know?'. Together they form a unique fingerprint.

Cite this